| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib
|
Carulli, Giovanni
|
|
2010
|
34 |
10 |
p. 1336-1339
4 p.
|
artikel
|
| 2 |
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma
|
Ferrario, A.
|
|
2010
|
34 |
10 |
p. e280-e281
nvt p.
|
artikel
|
| 3 |
A case of blast clearance on sorafenib in relapsed FLT3-ITD acute myeloid leukemia: Evidence of efficacy continues to mount
|
Fesler, Mark J.
|
|
2010
|
34 |
10 |
p. e268-e269
nvt p.
|
artikel
|
| 4 |
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment
|
Annereau, J.-P.
|
|
2010
|
34 |
10 |
p. 1383-1389
7 p.
|
artikel
|
| 5 |
B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene
|
Baldazzi, Carmen
|
|
2010
|
34 |
10 |
p. e282-e285
nvt p.
|
artikel
|
| 6 |
BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
|
An, Xin
|
|
2010
|
34 |
10 |
p. 1255-1268
14 p.
|
artikel
|
| 7 |
Central nervous system involvement at second relapse in acute promyelocytic leukemia treated with ATRA and chemotherapy
|
Kumar, Bijender
|
|
2010
|
34 |
10 |
p. e264-e265
nvt p.
|
artikel
|
| 8 |
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia
|
Bruey, Jean-Marie
|
|
2010
|
34 |
10 |
p. 1320-1324
5 p.
|
artikel
|
| 9 |
Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia
|
Cui, Lei
|
|
2010
|
34 |
10 |
p. 1314-1319
6 p.
|
artikel
|
| 10 |
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells
|
Litzinger, Mary T.
|
|
2010
|
34 |
10 |
p. 1351-1357
7 p.
|
artikel
|
| 11 |
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38− compartment
|
Pedranzini, Laura
|
|
2010
|
34 |
10 |
p. 1287-1295
9 p.
|
artikel
|
| 12 |
Differential NOD/SCID mouse engraftment of peripheral blood CD34+ cells and JAK2V617F clones from patients with myeloproliferative neoplasms
|
Fung, Tsz-Kan
|
|
2010
|
34 |
10 |
p. 1390-1394
5 p.
|
artikel
|
| 13 |
DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia
|
Tumer, Tugba Boyunegmez
|
|
2010
|
34 |
10 |
p. 1275-1281
7 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2010
|
34 |
10 |
p. CO2-
1 p.
|
artikel
|
| 15 |
Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation
|
Cao, Jiang
|
|
2010
|
34 |
10 |
p. 1374-1382
9 p.
|
artikel
|
| 16 |
Facilitating studies of cell proliferation in chronic lymphocytic leukemia
|
Macallan, Derek C.
|
|
2010
|
34 |
10 |
p. e273-e274
nvt p.
|
artikel
|
| 17 |
FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients
|
Braulke, Friederike
|
|
2010
|
34 |
10 |
p. 1296-1301
6 p.
|
artikel
|
| 18 |
FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657
|
Goemans, Bianca F.
|
|
2010
|
34 |
10 |
p. 1302-1307
6 p.
|
artikel
|
| 19 |
Genetic variation and the risk of acute lymphoblastic leukemia
|
Mullighan, Charles G.
|
|
2010
|
34 |
10 |
p. 1269-1270
2 p.
|
artikel
|
| 20 |
Genome-wide association study of childhood acute lymphoblastic leukemia in Korea
|
Han, Sohee
|
|
2010
|
34 |
10 |
p. 1271-1274
4 p.
|
artikel
|
| 21 |
Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA)
|
Koh, Youngil
|
|
2010
|
34 |
10 |
p. 1344-1350
7 p.
|
artikel
|
| 22 |
Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients
|
Pluta, Agnieszka
|
|
2010
|
34 |
10 |
p. 1308-1313
6 p.
|
artikel
|
| 23 |
Intravascular large B-cell lymphoma, an exclusively small vessel disease? A case report and review of literature
|
Yao, Xin
|
|
2010
|
34 |
10 |
p. e275-e277
nvt p.
|
artikel
|
| 24 |
Is there still a role for G-banding in CLL?
|
Machado, Rosangela Pinheiro Gonçalves
|
|
2010
|
34 |
10 |
p. e278-e279
nvt p.
|
artikel
|
| 25 |
Localized graft-versus-host disease of the skin provoked by radiotherapy
|
van de Donk, Niels W.C.J.
|
|
2010
|
34 |
10 |
p. e266-e267
nvt p.
|
artikel
|
| 26 |
NFκB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia
|
Nicholson, Lindsay
|
|
2010
|
34 |
10 |
p. 1366-1373
8 p.
|
artikel
|
| 27 |
Overdose with 16,000mg of imatinib mesylate
|
Dehours, Emilie
|
|
2010
|
34 |
10 |
p. e286-e287
nvt p.
|
artikel
|
| 28 |
Persistent detection of a novel MLL–SACM1L rearrangement in the absence of leukemia
|
Mori, Takeshi
|
|
2010
|
34 |
10 |
p. 1398-1401
4 p.
|
artikel
|
| 29 |
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents
|
Roussou, Maria
|
|
2010
|
34 |
10 |
p. 1395-1397
3 p.
|
artikel
|
| 30 |
Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: A case report
|
Winkler, J.
|
|
2010
|
34 |
10 |
p. e270-e272
nvt p.
|
artikel
|
| 31 |
Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells
|
Wang, Xiaofang
|
|
2010
|
34 |
10 |
p. 1325-1329
5 p.
|
artikel
|
| 32 |
Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors
|
Muranyi, Andrew L.
|
|
2010
|
34 |
10 |
p. 1358-1365
8 p.
|
artikel
|
| 33 |
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma—A report by the Polish Myeloma Study Group
|
Dmoszynska, Anna
|
|
2010
|
34 |
10 |
p. 1330-1335
6 p.
|
artikel
|
| 34 |
The MIF −173G/C polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population
|
Xue, Yao
|
|
2010
|
34 |
10 |
p. 1282-1286
5 p.
|
artikel
|
| 35 |
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)
|
Kastritis, Efstathios
|
|
2010
|
34 |
10 |
p. 1340-1343
4 p.
|
artikel
|
Tijdschrift beschrijving